Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.68 |
| ▸ | CYP46A1 | Q9Y6A2 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.68 |
| ▸ | OSBP | P22059 | 1/20 | 0.68 |
| ▸ | RORC | P51449 | 1/20 | 0.68 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.68 |
| ▸ | POLA1 | P09884 | 1/20 | 0.64 |
| ▸ | GRIN1 | Q05586 | 12/20 | 0.62 |
| ▸ | GRIN2B | Q13224 | 12/20 | 0.62 |
| ▸ | GRIN2A | Q12879 | 10/20 | 0.61 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27963054 | 1.00 | USP2 (0.68) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL27963051 | 1.00 | USP2 (0.68) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL2638134 | 0.93 | USP2 (0.68) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL27975861 | 0.93 | USP2 (0.68) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL2221515 | 0.92 | USP2 (0.67) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL2637585 | 0.92 | USP2 (0.67) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL8426935 | 0.92 | USP2 (0.67) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL8370401 | 0.91 | USP2 (0.64) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL318120 | 0.90 | USP2 (0.65) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL8159169 | 0.90 | OSBP (0.65) | USP2CYP46A1LMNAABCB1OSBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116969872-A | Production process of vitamin D3 and acid regulating kettle applied to production process | 淮南市健坤制药股份有限公司 | 2023-10-31 | — | — | CN | claimed |
| CN-103450214-B | Glucopyranosyl derivatives, its preparation method and in application pharmaceutically | SUNSHINE LAKE PHARMA CO.,LTD. (CN) | 2016-04-06 | — | — | CN | claimed |
| CN-119136831-A | Long-acting granulocyte macrophage-colony stimulating factor | 合作伙伴治疗有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-119101143-A | G protein biased apelin-13 polypeptide mutant and application thereof | 浙江大学 | 2024-12-10 | — | — | CN | disclosed |
| WO-2024125620-A2 | CRYSTAL FORM OF GLUCOPYRANOSYL DERIVATIVE AND USE THEREOF | 广东东阳光药业股份有限公司 | 2024-06-20 | — | — | WO | disclosed |
| CN-118206517-A | Eutectic crystal of glucopyranosyl derivative and application thereof | 广东东阳光药业股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-118206515-A | Crystal forms of glucopyranosyl derivative and use thereof | 广东东阳光药业股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-118206516-A | Eutectic crystal of glucopyranosyl derivative and application thereof | 广东东阳光药业股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-112209908-B | Glucopyranosyl derivatives and uses thereof | 东莞市东阳光新药研发有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-116969872-A | Production process of vitamin D3 and acid regulating kettle applied to production process | 淮南市健坤制药股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116969872-A | Production process of vitamin D3 and acid regulating kettle applied to production process | 淮南市健坤制药股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-1170943-C | Method of estalishing ApoAI target cell screening medicine system and screening HDL raising medicine | 上海医药(集团）总公司 | 2004-10-13 | — | — | CN | disclosed |
| EP-0648263-B1 | LIPASES FROM HYPHOZYMA | NOVOZYMES AS (DK) | 2002-09-18 | — | — | EP | disclosed |
| CN-1350061-A | Method of estalishing ApoAI target cell screening medicine system and screening HDL raising medicine | SHANGHAI MEDICINE GROUP CORP (CN) | 2002-05-22 | — | — | CN | disclosed |
| US-20020016312-A1 | Methods and compositions for the rapid and enduring relief of inadequate myocardial function | HEART CARE PARTNERS | 2002-02-07 | — | — | US | disclosed |
| US-6159993-A | Methods and compositions for the rapid and enduring relief of inadequate myocardial function | HEART CARE PARTNERS (US) | 2000-12-12 | — | — | US | disclosed |
| US-5861399-A | Methods and compositions for the rapid and enduring relief of inadequate myocardial function | HEART CARE PARTNERS (US) | 1999-01-19 | — | — | US | disclosed |
| US-5856163-A | POLYPEPTIDES; CULTURING | NOVO NORDISK A/S (DK) | 1999-01-05 | — | — | US | disclosed |
| EP-0648263-A1 | LIPASES FROM HYPHOZYMA | NOVO NORDISK A/S (DK) | 1995-04-19 | — | — | EP | disclosed |
| WO-1993024619-A1 | LIPASES FROM HYPHOZYMA | NOVO NORDISK A/S (DK) | 1993-12-09 | — | — | WO | disclosed |